Barclays PLC Raises Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)

Barclays PLC boosted its holdings in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 77.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,199 shares of the company’s stock after purchasing an additional 12,729 shares during the quarter. Barclays PLC owned approximately 0.05% of Health Catalyst worth $341,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of HCAT. Fairfield Bush & CO. purchased a new position in Health Catalyst during the first quarter worth approximately $25,000. Macquarie Group Ltd. purchased a new position in shares of Health Catalyst in the second quarter valued at approximately $26,000. Point72 Hong Kong Ltd purchased a new position in shares of Health Catalyst in the first quarter valued at approximately $33,000. State of Wyoming lifted its position in shares of Health Catalyst by 148.6% in the fourth quarter. State of Wyoming now owns 8,916 shares of the company’s stock valued at $95,000 after acquiring an additional 5,329 shares in the last quarter. Finally, Merriman Wealth Management LLC purchased a new position in shares of Health Catalyst in the fourth quarter valued at approximately $106,000. Hedge funds and other institutional investors own 86.63% of the company’s stock.

Insider Activity

In other news, CAO Jason Alger sold 2,370 shares of Health Catalyst stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $11.84, for a total value of $28,060.80. Following the completion of the sale, the chief accounting officer now directly owns 60,068 shares of the company’s stock, valued at $711,205.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders sold 6,014 shares of company stock valued at $70,529. 2.70% of the stock is currently owned by corporate insiders.

Health Catalyst Price Performance

HCAT stock opened at $11.46 on Thursday. The business has a fifty day moving average of $12.46 and a two-hundred day moving average of $12.31. The company has a quick ratio of 4.74, a current ratio of 4.74 and a debt-to-equity ratio of 0.58. The stock has a market cap of $652.76 million, a price-to-earnings ratio of -4.28 and a beta of 1.27. Health Catalyst, Inc. has a 52-week low of $6.40 and a 52-week high of $15.87.

Health Catalyst (NASDAQ:HCAT) last posted its earnings results on Tuesday, August 8th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.09. The company had revenue of $73.21 million during the quarter, compared to analysts’ expectations of $72.67 million. Health Catalyst had a negative return on equity of 16.49% and a negative net margin of 51.76%. As a group, research analysts anticipate that Health Catalyst, Inc. will post -1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on HCAT shares. Guggenheim downgraded Health Catalyst from a “buy” rating to a “neutral” rating in a research report on Wednesday, May 10th. Cantor Fitzgerald started coverage on Health Catalyst in a research report on Tuesday, August 1st. They issued an “overweight” rating and a $16.00 target price on the stock. Raymond James cut Health Catalyst from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 10th. Finally, Canaccord Genuity Group cut their price target on Health Catalyst from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $14.55.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases.